Answers are grounded in this paper and cite their sources.
Shows improved accuracy in predicting transcription factor binding sites, suggesting new insights into gene regulation.
Accurate identification of transcription factor binding sites (TFBSs) at single-nucleotide resolution remains a central challenge in deciphering gene expression regulatory networks. To improve the performance of existing computational models for predicting TFBSs across different cell types, we presented a deep learning model integrating channel and spatial attention mechanisms. In this study, we trained and tested the model using a comprehensive dataset that included ChIP-seq data from 51 groups, involving 10 core transcription factors (e.g., CTCF, EGR1, FOXA1) across 13 human cell lines (e.g., A549, GM12878, H1-hESC), and DNase-seq data from 13 datasets. The results demonstrated that this model exhibited superior performance across 23 TF-cell type combinations, achieving a mean area under the receiver operating characteristic curve (AUROC) of 0.986, with 91% of samples yielding an AUROC above 0.970. Additionally, the mean area under the precision-recall curve (AUPRC) reached 0.169, over 1,000-fold higher than the random baseline 0.000156. When compared to state-of-the-art models in the field, such as FactorNet, Leopard, and DeepGRN, our model outperformed them in terms of AUROC on nine shared TF-cell type datasets. Visualization analyses further confirmed that our model enabled accurate identification of cell-type-specific TFBSs. This study provides an efficient computational framework for precise cross-cell-type TFBS prediction, thereby facilitating in-depth investigations into gene expression regulatory mechanisms and the molecular pathogenesis of related diseases.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: